comparing glp-1 agonists Comparative efficacy and safety of receptor for weight reduction: A model-based meta-analysis of placebo-controlled trials Which GLP-1 Agonist is Best
Description
10.1210/jc.2016-2775 66
We offer free nationwide shipping on orders over $30 and on all qualifying Savings Packs
57 Diabetic ketoacidosis Although not readily apparent in RCT data, in May 2015 the US FDA added a warning that the use of SGLT2-I may lead to diabetic ketoacidosis (DKA)
Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial
A 40% reduction in triglycerides is what wed expect with a class of medications called fibrates
[DOI] [PMC free article] [PubMed] [Google Scholar] 40
